Scott Holmes, Chief Financial Officer, will leave the company on Dec. 31, 2019 (news posted on December 12 2019).
Amy Sullivan, who was Senior Vice President, Corporate Affairs, is promoted to Chief Strategy Officer (news posted on December 12 2019).
Paul van Hagen, who was Vice President, Finance, is promoted to Senior Vice President, Finance (news posted on December 12 2019).
Create an alert
to follow the executive moves at Kiadis Pharma.
Kiadis Pharma files first investigational new drug application with the U.S. FDA for natural killer (NK) cell therapy produced with PM21 - Kiadis Pharma
Kiadis Pharma to present at BioCapital Europe 2020 - Kiadis Pharma
Kiadis Pharma announces new data on ex-vivo FC21 expanded NK-cell therapy in 13 patients with relapsed/refractory acute myeloid leukemia will be presented at the European Society for Blood and Marrow Transplantation Annual Meeting* - Kiadis Pharma
Kiadis Pharma announces FDA clearance of clinical study by The Ohio State University in R/R AML with off-the-shelf NK cells from universal donors - Kiadis Pharma
Press Releases - Kiadis Pharma
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.